Gaucher's disease: Difference between revisions
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
==[[Gaucher's disease overview|Overview]]== | ==[[Gaucher's disease overview|Overview]]== | ||
==[[Gaucher's disease historical perspective|Historical Perspective]]== | |||
==[[Gaucher's disease classification|Classification]]== | |||
==[[Gaucher's disease pathophysiology|Pathophysiology]]== | ==[[Gaucher's disease pathophysiology|Pathophysiology]]== | ||
==[[Gaucher's disease differential diagnosis|Differentiating Gaucher's disease from other Diseases]]== | |||
==[[Gaucher's disease epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Gaucher's disease epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Gaucher's disease risk factors|Risk Factors]]== | ==[[Gaucher's disease risk factors|Risk Factors]]== | ||
==[[Gaucher's disease screening|Screening]]== | |||
==[[Gaucher's disease natural history|Natural History, Complications and Prognosis]]== | ==[[Gaucher's disease natural history|Natural History, Complications and Prognosis]]== | ||
Revision as of 14:32, 4 September 2012
| Gaucher's disease | |
 | |
|---|---|
| MRI: H-shaped vertebral bodies in a patient with Gaucher's disease. (Image courtesy of RadsWiki) | |
| ICD-10 | E75.2 (ILDS E75.220) |
| ICD-9 | 272.7 |
| OMIM | 230800 230900 231000 |
| DiseasesDB | 5124 |
| MedlinePlus | 000564 |
| MeSH | D005776 |
|
Gaucher's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gaucher's disease On the Web |
|
American Roentgen Ray Society Images of Gaucher's disease |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and related keywords: Cerebroside lipidosis syndrome, Gauchers disease, Gaucher splenomegaly, Gaucher syndrome, GD, Glucocerebrosidase deficiency, Glucocerebrosidosis, Glucosylceramidase deficiency, Glucosylceramide beta-glucosidase deficiency, Glucosylceramide lipidosis, Glucosyl cerebroside lipidosis, Kerasin histiocytosis, Kerasin lipoidosis, Kerasin thesaurismosis, Lipoid histiocytosis (kerasin type)
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Gaucher's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Endocrine, nutritional and metabolic pathology